Sunday, 18 May 2025
  
Login

Australia's most trusted
source of pharma news

Sunday, 18 May 2025
News

Rivals eat up leader board

Posted 16 July 2024 AM

A changing of the guard of the world's top selling drugs is just around the corner with two rival companies slated to monopolise the leader board, raking in more than US$100 billion in combined sales a year.

According to the latest report from analytics firm Evaluate, half of the top 10 selling prescription drugs in 2030 will be treatments for metabolic diseases, such as obesity and diabetes, sponsored by Novo Nordisk and Eli Lilly.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (12)

Clinical & Medical, R&D (6)

Regulatory, Pharmacovigilance & QA (4)

Devices (1)

Other (14)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.